Literature DB >> 31801888

Paroxysmal slow cortical activity in Alzheimer's disease and epilepsy is associated with blood-brain barrier dysfunction.

Dan Z Milikovsky1, Jonathan Ofer1, Vladimir V Senatorov2,3,4, Aaron R Friedman3, Ofer Prager1, Liron Sheintuch1, Netta Elazari1, Ronel Veksler1, Daniel Zelig1, Itai Weissberg1, Guy Bar-Klein5, Evyatar Swissa1, Erez Hanael6, Gal Ben-Arie7, Osnat Schefenbauer1, Lyna Kamintsky8, Rotem Saar-Ashkenazy1,9, Ilan Shelef7, Merav H Shamir6, Ilan Goldberg10, Amir Glik11,12,13, Felix Benninger11,13, Daniela Kaufer2,3, Alon Friedman14,8.   

Abstract

A growing body of evidence shows that epileptic activity is frequent but often undiagnosed in patients with Alzheimer's disease (AD) and has major therapeutic implications. Here, we analyzed electroencephalogram (EEG) data from patients with AD and found an EEG signature of transient slowing of the cortical network that we termed paroxysmal slow wave events (PSWEs). The occurrence per minute of the PSWEs was correlated with level of cognitive impairment. Interictal (between seizures) PSWEs were also found in patients with epilepsy, localized to cortical regions displaying blood-brain barrier (BBB) dysfunction, and in three rodent models with BBB pathology: aged mice, young 5x familial AD model, and status epilepticus-induced epilepsy in young rats. To investigate the potential causative role of BBB dysfunction in network modifications underlying PSWEs, we infused the serum protein albumin directly into the cerebral ventricles of naïve young rats. Infusion of albumin, but not artificial cerebrospinal fluid control, resulted in high incidence of PSWEs. Our results identify PSWEs as an EEG manifestation of nonconvulsive seizures in patients with AD and suggest BBB pathology as an underlying mechanism and as a promising therapeutic target.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2019        PMID: 31801888     DOI: 10.1126/scitranslmed.aaw8954

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  20 in total

1.  Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease.

Authors:  Giuseppe Barisano; Axel Montagne; Kassandra Kisler; Julie A Schneider; Joanna M Wardlaw; Berislav V Zlokovic
Journal:  Nat Cardiovasc Res       Date:  2022-02-07

Review 2.  TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications.

Authors:  Jian Luo
Journal:  Biomedicines       Date:  2022-05-23

3.  DCAF1 regulates Treg senescence via the ROS axis during immunological aging.

Authors:  Zengli Guo; Gang Wang; Bing Wu; Wei-Chun Chou; Liang Cheng; Chenlin Zhou; Jitong Lou; Di Wu; Lishan Su; Junnian Zheng; Jenny P-Y Ting; Yisong Y Wan
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 4.  Neuronal regulation of the blood-brain barrier and neurovascular coupling.

Authors:  Luke Kaplan; Brian W Chow; Chenghua Gu
Journal:  Nat Rev Neurosci       Date:  2020-07-07       Impact factor: 34.870

5.  Automatic wavelet-based assessment of behavioral sleep using multichannel electrocorticography in rats.

Authors:  Anastasiya Runnova; Maksim Zhuravlev; Anton Kiselev; Rodion Ukolov; Kirill Smirnov; Anatoly Karavaev; Evgenia Sitnikova
Journal:  Sleep Breath       Date:  2021-03-25       Impact factor: 2.816

Review 6.  Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.

Authors:  Ajay Uprety; Yeji Kang; Soo Young Kim
Journal:  Arch Pharm Res       Date:  2021-05-24       Impact factor: 4.946

7.  Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers.

Authors:  Fanny M Elahi; Senyo B Ashimatey; Daniel J Bennett; Samantha M Walters; Renaud La Joie; Xuejuan Jiang; Amy Wolf; Yann Cobigo; Adam M Staffaroni; Howie J Rosen; Bruce L Miller; Gil D Rabinovici; Joel H Kramer; Ari J Green; Amir H Kashani
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-11

Review 8.  Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy.

Authors:  Samantha L Hodges; Joaquin N Lugo
Journal:  Epilepsy Res       Date:  2020-01-30       Impact factor: 2.991

Review 9.  Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.

Authors:  Evelyne Gozal; Rekha Jagadapillai; Jun Cai; Gregory N Barnes
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

10.  Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology.

Authors:  Miriam Ries; Helena Watts; Bibiana C Mota; Maria Yanez Lopez; Cornelius K Donat; Nicoleta Baxan; James A Pickering; Tsz Wing Chau; Annika Semmler; Brinda Gurung; Robertas Aleksynas; Laura Abelleira-Hervas; Soha Jamshed Iqbal; Carmen Romero-Molina; Gerard Hernandez-Mir; Antonio d'Amati; Chris Reutelingsperger; Marc H Goldfinger; Steve M Gentleman; Fred Van Leuven; Egle Solito; Magdalena Sastre
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.